The Vantage Urologic Institute is dedicated to the rapidly growing field of men’s health. Our highly trained professionals and expert staff excel in the diagnosis and treatment of urologic conditions that specifically affect men such as prostate cancer, prostate enlargement (BPH), erectile dysfunction, low testosterone, Peyronie’s disease, and ejaculatory disorders.
Urologic Oncology (Cancer)
The Vantage Urologic Institute offers the most advanced, innovative treatments for all types of tumors and malignancies of the male genitourinary system including bladder cancer, kidney cancer, prostate cancer, testicular cancer and cancer of the adrenal glands, penis, ureters, and urethra. Our physicians tailor cancer treatment for each of our patients based on the type and extent of their disease, which therapy promises the best chance of a cure, and how each treatment may affect quality of life.
Other than skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society’s estimates for prostate cancer in the United States for 2018 are:
- About 164,690 new cases of prostate cancer.
- About 29,430 deaths from prostate cancer.
About 1 man in 9 will be diagnosed with prostate cancer during his lifetime. Prostate cancer develops mainly in older men and in African-American men. About 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66.
Advanced prostate cancer is when cancer has spread beyond the prostate. It can also be when the cancer has not responded to hormone treatment. Advanced prostate cancer can be:
Metastatic – Cancer cells have spread beyond the prostate.
Biochemical recurrence – PSA (prostate specific antigen) level has risen after the first treatment(s) with no other sign of cancer.
Castrate-resistant prostate cancer (CRPC) – PSA has risen, even after surgery to remove the testicles or drugs to block testosterone.
Metastatic castrate-resistant prostate cancer (mCRPC) – PSA has risen after hormone treatment, AND cancer has spread to other parts of the body.
The American Cancer Society’s estimates for bladder cancer in the United States for 2018 are:
- About 81,190 new cases of bladder cancer (about 62,380 in men and 18,810 in women).
- About 17,240 deaths from bladder cancer (about 12,520 in men and 4,720 in women).
The rates of new bladder cancers and of cancer deaths and have been dropping slightly in women in recent years. In men, incidence rates have been decreasing and death rates have been stable.
The American Cancer Society’s most recent estimates for kidney cancer in the United States are for 2018:
- About 63,340 new cases of kidney cancer (42,680 in men and 22,660 in women) will occur.
- About 14,970 people (10,010 men and 4,960 women) will die from this disease.
These numbers include all types of kidney and renal pelvis cancers.
Prostate and Urinary Health
Conditions associated with an enlarging prostate often become increasingly bothersome to men as they age. The impact on lifestyle from interruption of sleep, discomfort and infections and even leakage of urine can be significant. The experienced physicians at the Vantage Urologic Institute are skilled in the diagnosis, treatment, and management of prostate and urinary conditions.
Benign prostatic hyperplasia, or BPH, is a condition in which the prostate enlarges as men get older. Over 70% of men in their 60s have BPH symptoms so it is very common. While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man’s quality of life.
Urinary incontinence is a problem with bladder and sphincter control. It is the uncontrolled leaking of urine. Millions of Americans, about 1 out of 2 of all women and 1 out of 4 men, suffer from urinary incontinence symptoms.
Prostatitis, an inflammation or infection of the prostate gland, is a common and usually painful condition that can affect men of all ages. Up to 50 percent of all men experience prostatitis-like symptoms at some point during their lifetimes.
Male Sexual Health
The Vantage Urologic Institute offers comprehensive and innovative medical care for the treatment of male sexual health issues including erectile dysfunction (ED), premature ejaculation, Peyronie’s disease, testosterone deficiency and sexual rehabilitation following prostate cancer treatment. We understand that sexual dysfunction can significantly affect a man’s quality of life, self-image, and confidence, and result in problems with interpersonal relations.
Professionals at the Vantage Urologic Institute have expertise identifying the causes of sexual dysfunction and offer the full range of treatments, from the latest medical and surgical approaches to behavioral therapies.
Erectile dysfunction (ED) is defined as the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance and/or satisfaction.
Erectile dysfunction (ED) is the most common sex problem that men report to their doctor. It affects as many as 30 million men.
ED is defined as trouble getting or keeping an erection that’s firm enough for sex.
Though it’s not rare for a man to have some problems with erections from time to time, ED that is progressive or happens routinely with sex is not normal, and it should be treated.
Testosterone is the male sex hormone that is made in the testicles. In men, testosterone is needed for normal male sexual development and function.
Peyronie’s disease is a medical condition characterized by the development of a lump on the shaft of the penis. This lump is a scar (plaque) that forms on the lining (tunica albuginea) of the penile erectile body (corpus cavernosum). It is believed to be the result of direct injury to the penis. Early on following the trauma, an inflammatory reaction occurs, often bringing a man’s attention to the problem because of pain associated with his erection. With time, the inflammation progresses, and a scar develops.
Premature ejaculation (PE) is ejaculation that occurs sooner than desired, either before or shortly after penetration, causing distress to either one or both partners. Premature ejaculation is a poorly understood condition that effects up to 30% of the male population and is considered as the most common sexual disorder in men. It often causes negative personal consequences, such as distress, bother, frustration, and/or the avoidance of sexual intimacy.
Rejuvenation & Aesthetics
The Vantage Urologic Institute is pleased to offer a variety of rejuvenation and aesthetic services for men tailored to meet the varying needs of each individual. When it comes to aesthetic procedures, men are increasingly benefiting from a range of highly effective and minimally invasive treatments that require little to no downtime while improving and strengthening their masculine features, helping them to look better, feel younger, and more confident.
Many men are faced with the common effects of aging including facial wrinkles, creases and folds, thin or flat lips, and hollow areas under the eyes, temples, and cheeks. Fortunately, there are numerous injectable treatments like Botox and dermal fillers available to instantly reverse the signs of aging.
Hyperhidrosis is a medical condition that involves excessive sweating — under the arms, on the hands, and feet, or on the forehead. Severe hyperhidrosis often goes undiagnosed, misdiagnosed, and untreated due to lack of awareness.
Male pattern baldness typically begins on the top and front of the head, resulting in thinning and eventual hair loss. It is caused by a combination of genetics and a loss of hormones. Although this condition cannot be cured, it can be treated and improved with hair restoration treatments.
The goal of penile rejuvenation is to stimulate blood flow to the penis to help optimize erections, sensitivity, and sexual performance.